Last reviewed · How we verify

NCT04989998

Patient Outcomes Using HIP7 Software as Compared to Conventional THA

Withdrawn NA Last updated 29 July 2022
What this trial tests

NA trial testing Hip7 Software on Kick/ CORI platforms in Hip Replacement. Withdrawn.

Timeline
30 September 2021
Primary endpoint
31 October 2024
31 October 2024

Quick facts

Lead sponsorSmith & Nephew Orthopaedics AG
PhaseNA
StatusWithdrawn
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposetreatment
Start date30 September 2021
Primary completion31 October 2024
Estimated completion31 October 2024

Drugs / interventions tested

Conditions studied

Sponsor

Smith & Nephew Orthopaedics AG

Who can join

18 and older, any sex, with Hip Replacement. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The study is designed to demonstrate how Hip7 software can lead to improved patient outcomes compared to conventional procedures with standard instrumentation for total hip arthroplasties (THA) surgery.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Hip Replacement

Currently open trials in the same condition.

Other Smith & Nephew Orthopaedics AG trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04989998.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing